Indus Capital Partners’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Indus Capital Partners’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-330,339	Closed	-$26M	–	61
2017 Q4	$26M	Buy	+330,339	New	+$27.5M	2.54%	13
2017 Q3	–	Sell	-278,407	Closed	-$31.5M	–	56
2017 Q2	$31.5M	Sell	278,407 -4,143	-1%	-$463K	3.45%	6
2017 Q1	$33.3M	Buy	282,550 +115,446	+69%	+$12.3M	4.39%	7
2016 Q4	$18M	Sell	167,104 -78,133	-32%	-$9.13M	2.33%	8
2016 Q3	$30.5M	Sell	245,237 -103,973	-30%	-$12.3M	2.89%	7
2016 Q2	$37.1M	Sell	349,210 -29,308	-8%	-$3.4M	3.59%	8
2016 Q1	$43.3M	Buy	378,518 +175,918	+87%	+$20.6M	4.22%	8
2015 Q4	$28.9M	Buy	202,600 +152,600	+305%	+$17.6M	4.04%	7
2015 Q3	$4.49M	Buy	+50,000	New	+$5.28M	0.6%	25

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Indus Capital Partners's CBPO Position: Q1 2018 in Review

Indus Capital Partners sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2018, closing a stake of 330,339 shares — an estimated $26M sold.

Indus Capital Partners first reported a position in CBPO in Q3 2015 and held it in 9 quarters. The position peaked at $43.3M in Q1 2016. 86 funds tracked by Wall St. Rank hold CBPO as of Q1 2018.

Indus Capital Partners reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2018 after selling out during the quarter.
Indus Capital Partners sold 330,339 China Biologic Products Holdings, Inc. shares in Q1 2018, an estimated $26M.
Indus Capital Partners first reported a position in China Biologic Products Holdings, Inc. in Q3 2015 and held it in 9 quarters.
Indus Capital Partners's China Biologic Products Holdings, Inc. position peaked at $43.3M in Q1 2016.
86 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2018.

Based on Indus Capital Partners's 13F filing for Q1 2018, filed 15 May 2018.